Eglal I. Amer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eglal I. Amer has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Amal M Khalil
Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
1 shared publication - Ashraf Mohamed Barakat
Department of Zoonotic Diseases, National Research Centre, Dokki, Giza, Egypt
1 shared publication - Hamida M Aboushleib
Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt
1 shared publication - Hayam A Sadaka
Medical Parasitology Department, Faculty of Medicine, Alexandria University, Egypt
1 shared publication - Hoda Mahrous
Industrial Biotechnology Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), Sadat City University, Egypt
1 shared publication - Iman Fathy Abou-El-Naga
Medical Parasitology Department, Faculty of Medicine, Alexandria University, Egypt
1 shared publication
Latest Publications
- Open Access
- 20 July 2016
- Published by Universidad de Costa Rica in Revista de Biologia Tropical
- Vol. 64 (4) , 1747-1757
Total protein composition of young and adult Biomphalaria alexandrina snails with different compatibilities to Schistosoma mansoni infection
In the current study differentiation of the total proteins among Biomphalaria alexandrina snails at different ages was done to identify the proteins responsible for the snails’ compatibility outcome. The work was conducted on snails that differ in their age and the genetic backgrounds. Four subgroups from the progeny of self reproduced susceptible and resistant snails were studies. Infection rates of these subgroups (young susceptible, adult susceptible, young resistant and adult resistant) were 90%, 75%, 40% and 0% respectively. Using Sodium dodecyl sulphate polyacrylamide gel electrophoresis, differences in protein expression were shown between adult and young snails in different subgroups. Dice similarity coefficient was calculated to determine percentage band sharing among the experimental subgroups. The results revealed that the combination of similarities between both age and compatibility status of the snails has led to the highest similarity coefficient followed by the combination of similarities of both genetic origin and age although they differ in the compatibility status. On the other hand, the differences in the genetic background, age and compatibility status have led to the least similarity index. It was also found that in young snails the genetic background plays the main role in determination of their compatibility, while the internal defense system has the upper hand in determination of adult compatibility. Further characterization of the shared protein bands among the studied subgroups is needed to clarify their role in host-parasite relationship.
- 20 July 2016
- Published by Universidad de Costa Rica in Revista de Biologia Tropical
- Vol. 64 (4) , 1747-1757
Open AccessTotal protein composition of young and adult Biomphalaria alexandrina snails with different compatibilities to Schistosoma mansoni infection
In the current study differentiation of the total proteins among Biomphalaria alexandrina snails at different ages was done to identify the proteins responsible for the snails’ compatibility outcome. The work was conducted on snails that differ in their age and the genetic backgrounds. Four subgroups from the progeny of self reproduced susceptible and resistant snails were studies. Infection rates of these subgroups (young susceptible, adult susceptible, young resistant and adult resistant) were 90%, 75%, 40% and 0% respectively. Using Sodium dodecyl sulphate polyacrylamide gel electrophoresis, differences in protein expression were shown between adult and young snails in different subgroups. Dice similarity coefficient was calculated to determine percentage band sharing among the experimental subgroups. The results revealed that the combination of similarities between both age and compatibility status of the snails has led to the highest similarity coefficient followed by the combination of similarities of both genetic origin and age although they differ in the compatibility status. On the other hand, the differences in the genetic background, age and compatibility status have led to the least similarity index. It was also found that in young snails the genetic background plays the main role in determination of their compatibility, while the internal defense system has the upper hand in determination of adult compatibility. Further characterization of the shared protein bands among the studied subgroups is needed to clarify their role in host-parasite relationship.
- 1 October 2015
- Published by Elsevier in Experimental Parasitology
- Vol. 157, 12-22
Could miltefosine be used as a therapy for toxoplasmosis?
- 1 October 2015
- Published by Elsevier in Experimental Parasitology
- Vol. 157, 12-22
Could miltefosine be used as a therapy for toxoplasmosis?
- Open Access
- 24 March 2015
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 15 (1) , 1-16
Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model
Schistosoma mansoni infection represents a major cause of morbidity and mortality in many areas of the developing world. Effective vaccines against schistosomiasis are not available and disease management relies mainly on treatment with the anthelmintic drug praziquantel. Several promising schistosomal antigens have been evaluated for vaccine efficacy such as Sm14, Sm29 and tetraspanins. However, most investigators examine these promising antigens in animal models individually rather than in properly adjuvanted antigen combinations. In the present study, we made a recombinant fusion protein comprised of the promising schistosomal antigens Sm14 and Sm29. The fusion protein, FSm14/29, was administered to Swiss albino mice either unadjuvanted or adjuvanted with polyinosinic-polycytidylic acid adjuvant, poly(I:C). Mice were challenged with S. mansoni cercariae and different parasitological/immunological parameters were assessed seven weeks post-challenge. Data were analyzed using the ANOVA test with post-hoc Tukey-Kramer test. Mice pre-immunized with unadjuvanted or poly(I:C)-adjuvanted fusion protein showed reduction of adult worm burden of 44.7 and 48.4%, respectively. In addition, significant reduction of tissue egg burdens was observed in mice immunized with the fusion protein when compared with the infected saline/adjuvant negative control groups and groups immunized with the individual Sm14 and Sm29 antigens. Light microscope and scanning electron microscope (SEM) investigation of adult worms recovered from FSm14/29-immunized mice revealed appreciable morphological damage and tegumental deformities. Histopathological examination of liver sections of immunized mice demonstrated reduced granulomatous and inflammatory reactions when compared with infected unvaccinated mice or mice immunized with the individual Sm14 and Sm29 antigens. The findings presented in this study highlight the importance of the fusion protein FSm14/29 as a potential vaccine candidate that is worthy of further investigation.
- 24 March 2015
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 15 (1) , 1-16
Open AccessFusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model
Schistosoma mansoni infection represents a major cause of morbidity and mortality in many areas of the developing world. Effective vaccines against schistosomiasis are not available and disease management relies mainly on treatment with the anthelmintic drug praziquantel. Several promising schistosomal antigens have been evaluated for vaccine efficacy such as Sm14, Sm29 and tetraspanins. However, most investigators examine these promising antigens in animal models individually rather than in properly adjuvanted antigen combinations. In the present study, we made a recombinant fusion protein comprised of the promising schistosomal antigens Sm14 and Sm29. The fusion protein, FSm14/29, was administered to Swiss albino mice either unadjuvanted or adjuvanted with polyinosinic-polycytidylic acid adjuvant, poly(I:C). Mice were challenged with S. mansoni cercariae and different parasitological/immunological parameters were assessed seven weeks post-challenge. Data were analyzed using the ANOVA test with post-hoc Tukey-Kramer test. Mice pre-immunized with unadjuvanted or poly(I:C)-adjuvanted fusion protein showed reduction of adult worm burden of 44.7 and 48.4%, respectively. In addition, significant reduction of tissue egg burdens was observed in mice immunized with the fusion protein when compared with the infected saline/adjuvant negative control groups and groups immunized with the individual Sm14 and Sm29 antigens. Light microscope and scanning electron microscope (SEM) investigation of adult worms recovered from FSm14/29-immunized mice revealed appreciable morphological damage and tegumental deformities. Histopathological examination of liver sections of immunized mice demonstrated reduced granulomatous and inflammatory reactions when compared with infected unvaccinated mice or mice immunized with the individual Sm14 and Sm29 antigens. The findings presented in this study highlight the importance of the fusion protein FSm14/29 as a potential vaccine candidate that is worthy of further investigation.
- 1 November 2014
- Published by Elsevier in Experimental Parasitology
- Vol. 146, 52-63
Therapeutic enhancement of newly derived bacteriocins against Giardia lamblia
- 1 November 2014
- Published by Elsevier in Experimental Parasitology
- Vol. 146, 52-63
Therapeutic enhancement of newly derived bacteriocins against Giardia lamblia